Clinical and immunological characteristics of type 1 diabetes mellitus in a northwestern Colombian population

被引:10
|
作者
Tobon, G. J.
Arango, A.
Abad, V.
Garcia, J.
Cuervo, H.
Velasquez, A.
Angel, I. D.
Vega, P.
Abad, A.
Anaya, J. -M.
机构
[1] Corp Invest Biol, Cellular Biol & Immunogenet Unit, Medellin, Colombia
[2] Univ Pontificia Bolivariana, Sch Med, Clin Univ Bolivariana, Medellin, Colombia
[3] Hosp Pablo Tobon Uribe, Medellin, Colombia
[4] Antioquena Diabet, Medellin, Colombia
[5] Lab Endocrinol, Medellin, Colombia
[6] Univ Nacl Rosario, Medellin, Colombia
关键词
type; 1; diabetes; GADA; IA-2A; IAA; Colombia;
D O I
10.1016/j.diabres.2005.10.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We underwent a project aimed to define the clinical and immunological characteristics of type 1 diabetes (T1D) in a Colombian population. This was a multicenter and cross-sectional study. Patients were systematically interviewed and their medical records reviewed, using a questionnaire that sought information about demographic, clinical and immunological characteristics. Glutamic acid decarboxylase antibodies (GADA), tyrosine phosphatase antibodies (IA-2A) and insulin antibodies (IAA) were examined by radioimmunoassay. There were 107 patients with T1D. Male:female ratio was 1:1. Half of the patients developed diabetes ketoacidosis at onset. GADA, IA-2A, and IAA were detected in 45%, 40%, and 69% of the cases, respectively. GADA positive patients were older and had a less duration of disease than patients without these autoantibodies (p < 0.01). Association between breast feeding with the presence of antibodies or clinical characteristics was not observed. The results highlight some differences of T1D expression according,to geographic location and ethnicity. Differences in age at onset and clinical variables may point to an environmental factor or deficient access to health care system. Genetic studies underway will provide important information in this population. These results might help to define public health policies in our population to improve T1D diagnosis, patients' quality of life and their outcome. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:170 / 175
页数:6
相关论文
共 50 条
  • [21] Clinical Characteristics of 261 Cases of Hospitalized Patients with Type 1 Diabetes Mellitus
    Jing Yang
    Mei-cen Zhou
    Kai Feng
    Ou Wang
    Hua-bing Zhang
    Wei Li
    Fan Ping
    Yu-xiu Li
    Chinese Medical Sciences Journal, 2016, 31 (02) : 69 - 75
  • [22] Type 1 diabetes mellitus in people with pharmacoresistant epilepsy: Prevalence and clinical characteristics
    Keezer, Mark R.
    Novy, Jan
    Sander, Josemir W.
    EPILEPSY RESEARCH, 2015, 115 : 55 - 57
  • [23] Clinical characteristics and diabetes associated autoantibodies in patients with both type 1 diabetes mellitus and asthma
    Rachmiel, M.
    Bloch, O.
    Bistritzer, Z.
    Weintrob, N.
    Ofan, R.
    Bloch, K.
    Vardi, P.
    Rapoport, M. J.
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2006, 19 (08): : 1001 - 1006
  • [24] Diabetes mellitus Type 1: Clinical research
    Dib, Sergio Atala
    Tschiedel, Balduino
    Nery, Marcia
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2008, 52 (02) : 143 - 145
  • [25] Early Onset of Type 1 Diabetes in Kuwait: Distinct Clinical, Metabolic, and Immunological Characteristics
    Al-Abdulrazzaq, Dalia
    Qabazard, Mariam
    Al-Jasser, Fahad
    Al-Anizi, Ayed
    Al-Basari, Iman
    Mandani, Fawziya
    Al-Kandari, Hessa
    MEDICAL PRINCIPLES AND PRACTICE, 2024, 33 (06) : 555 - 561
  • [26] Albuminuria in a population based study of Danish patients with type 1 diabetes mellitus: Prevalence clinical characteristics and risk factors
    Eshoj, O
    Borch-Johnsen, K
    Feldt-Rasmussen, B
    Sjolie, AK
    Beck-Nielsen, H
    DIABETOLOGIA, 2001, 44 : A263 - A263
  • [27] Immunological changes in subjects positive for diabetes-associated autoantibodies at preclinical and clinical stages of type 1 diabetes mellitus
    Popova, V.
    Zak, K.
    Mankovsky, B.
    DIABETOLOGIA, 2008, 51 : S26 - S27
  • [28] Prevalence of markers of celiac disease in Colombian children with diabetes mellitus type 1
    Alberto Velasco-Benitez, Carlos
    Ruiz-Extremera, Angeles
    Mary Matallana-Rhoades, Audrey
    Carolina Giraldo-Lora, Sandra
    Jimena Ortiz-Rivera, Claudia
    COLOMBIA MEDICA, 2018, 49 (04): : 273 - 279
  • [29] Preserving β cells in type 1 diabetes mellitus:: The role of immunological tolerance
    Pillemer, Stanley R.
    DRUG DEVELOPMENT RESEARCH, 2008, 69 (03) : 153 - 157
  • [30] THE IMMUNOLOGICAL NETWORK IN THE PATHOGENESIS OF TYPE-1 DIABETES-MELLITUS
    SIGNORE, A
    LAMPETER, E
    CAVALLO, MG
    VISALLI, N
    POZZILLI, P
    EOS-RIVISTA DI IMMUNOLOGIA ED IMMUNOFARMACOLOGIA, 1989, 9 (02): : 63 - 67